Andere Kunden interessierten sich auch für
![Epigenetics in Cardiac Disease]( "Epigenetics in Cardiac Disease")
Epigenetics in Cardiac Disease110,99 €![Non-coding RNAs in the Vasculature]( "Non-coding RNAs in the Vasculature")
Non-coding RNAs in the Vasculature74,99 €![Chromosome Structure and Aberrations]( "Chromosome Structure and Aberrations")
Chromosome Structure and Aberrations110,99 €![The Male Role in Pregnancy Loss and Embryo Implantation Failure]( "The Male Role in Pregnancy Loss and Embryo Implantation Failure")
The Male Role in Pregnancy Loss and Embryo Implantation Failure74,99 €![Decoding Neural Circuit Structure and Function]( "Decoding Neural Circuit Structure and Function")
Decoding Neural Circuit Structure and Function111,99 €![Janeway Immunologie]( "Janeway Immunologie")
Janeway Immunologie109,99 €![Gene Therapy and Cell Therapy Through the Liver]( "Gene Therapy and Cell Therapy Through the Liver")
Gene Therapy and Cell Therapy Through the Liver74,99 €
This book explores the role of endothelial progenitor cells (EPCs) in the context of regenerative medicine (RegMed). In particular, it reveals the value of RegMed as a new TM branch intended to improve the health and quality of life, by restoring, maintaining or enhancing tissue and functions of organs.
The book is divided into three chapters, the first of which describes the relevance of translational medicine (TM) as a new research approach to counteract the imposing challengeof age-related diseases. Of the diverse RegMed approaches, particular attention is paid to stem/progenitor cell-based therapies, their benefits and shortcomings, as well as to the description of types of stem and progenitor cells considered for regenerative cell therapies, such as EPCs as emerging candidates for RegMed applications.
In turn, the second chapter outlines the clinical relevance of EPCs as both potential predictors, diagnostic and prognostic biomarkers of age-related diseases and therapeutic agents,discussing their advantages, disadvantages, and conflicting data.
Chapter three proposes a potential roadmap for revising the findings and creating a clearer picture of valid data, which can provide support for various important aspects, i.e.isolating and characterizing EPCs by establishing standardized criteria for EPC research, identifying appropriate sub-populations for cell therapy, timing, dosing, priming of cells,and defining delivery modes for different applications.
The book concludes with an overview of innovative strategies that could improve the efficacy of cell therapy at all levels, including cell priming, bio-nanotechnology, and tissue engineering.
The book is divided into three chapters, the first of which describes the relevance of translational medicine (TM) as a new research approach to counteract the imposing challengeof age-related diseases. Of the diverse RegMed approaches, particular attention is paid to stem/progenitor cell-based therapies, their benefits and shortcomings, as well as to the description of types of stem and progenitor cells considered for regenerative cell therapies, such as EPCs as emerging candidates for RegMed applications.
In turn, the second chapter outlines the clinical relevance of EPCs as both potential predictors, diagnostic and prognostic biomarkers of age-related diseases and therapeutic agents,discussing their advantages, disadvantages, and conflicting data.
Chapter three proposes a potential roadmap for revising the findings and creating a clearer picture of valid data, which can provide support for various important aspects, i.e.isolating and characterizing EPCs by establishing standardized criteria for EPC research, identifying appropriate sub-populations for cell therapy, timing, dosing, priming of cells,and defining delivery modes for different applications.
The book concludes with an overview of innovative strategies that could improve the efficacy of cell therapy at all levels, including cell priming, bio-nanotechnology, and tissue engineering.